Where to now? AVERT answered an important question, but raised many more
The AVERT trial was a Phase 3 randomised trial with over 2100 subjects designed to end the
controversy about the early mobilisation of stroke patients. It’s sounds intuitive doesn’t it, if a patient has a stroke get them up and moving as soon as possible get the blood flowing and consequently the patient healing faster.
But this wasn’t the case, and the stroke community, especially the rehab and recovery arm were collectively shocked by the results which indicated that early mobilization may actually cause harm. Carmen Lahiff-Jenkins, the Managing Editor of our flagship publication International Journal of Stroke, spoke to Mark Bayley from the Toronto Rehabilitation Institute, Brain and Spinal Cord Rehabilitation Program, and University of Toronto Faculty of Medicine Physical Medicine and Rehabilitation, Toronto Canada.
The AVERT trial was a Phase 3 randomised trial with over 2100 subjects designed to end the
controversy about the early mobilisation of stroke patients. It’s sounds intuitive doesn’t it, if a patient has a stroke get them up and moving as soon as possible get the blood flowing and consequently the patient healing faster.
But this wasn’t the case, and the stroke community, especially the rehab and recovery arm were collectively shocked by the results which indicated that early mobilization may actually cause harm. Carmen Lahiff-Jenkins, the Managing Editor of our flagship publication International Journal of Stroke, spoke to Mark Bayley from the Toronto Rehabilitation Institute, Brain and Spinal Cord Rehabilitation Program, and University of Toronto Faculty of Medicine Physical Medicine and Rehabilitation, Toronto Canada.
